Dolastatin 10
海兔毒素10
Report date: 2023/04/25 13:58:58
NME
Base Information
Drug NameDolastatin 10
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[11]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Institute
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesBarbara Ann Karmanos Cancer InstituteUniversity Of VermontThe University Of Chicago +[5]
Active IndicationsN/A
Inactive Indications +[11]
Other Information
ATC CodeN/A
Related LinksKEGG